02.03.10
Ganeden Biotech, Cleveland, OH, maker of the patented probiotic strain GanedenBC30, has partnered with Pathway International Pty Ltd., which will distribute GanedenBC30 in all Australian and New Zealand markets.
The partnership will provide growth opportunities for Ganeden Biotech through increased distribution channels and access to an exclusive international supply chain network of leading manufacturers in Australia and New Zealand.
"Partnering with Pathway International is an important step in achieving our global expansion goals for 2010," said Andrew Lefkowitz, president and CEO, Ganeden Biotech. "We are confident that Pathway International's proven track record in successfully distributing innovative health and wellness ingredients will help our probiotic reach consumers in these markets looking to improve their digestive health and boost immunity with probiotic-enhanced food, beverage and supplement products."